- Home
- / Biofrontera US
- / Financials
Header placeholder lorem ipsum dolor sit amet, consectetur adipiscing elit.
Biofrontera US financials data including stock price, CreditSafe score, income statement, balance sheet, and cash flow.
Stock Price
$0.9
2024-10-29
Market Capitalization
$5.1 M
2024-10-29
Revenue
$41.7 M
FY, 2025
CreditSafe Score
?
Score changed on Jun 09, 2026
Premium Content only available in Craft’s Intelligence Portal
View 30+ financial ratio metrics including price-to-earnings ratio, debt-to-assets ratio, gross profit margin, and more.
Financial ratio metrics help evaluate the financial strength of a company, and help raise red flags that can indicate potential risk, fulfillment challenges, or even possible bankruptcy.
Learn moreFinancial Statements
| USD | FY, 2021 | FY, 2022 | FY, 2023 | FY, 2024 | FY, 2025 |
|---|---|---|---|---|---|
| Revenue | 24.1M | 28.7M | 34.1M | 37.3M | 41.7M |
| General and administrative expense | 36.5M | 35.1M | 39.0M | 16.3M | 37.8M |
| Operating expense total | 35.1M | 18.4M | 41.5M | ||
| EBIT | (25.2M) | (18.6M) | (22.7M) | (17.2M) | (11.3M) |
| EBIT margin, % | -64.8% | -46.1% | -27.2% | ||
| Investment income | 1.7M | (7.4M) | (14.0K) | 2.0K | |
| Interest income | 132.0K | 71.0K | |||
| Interest expense | (344.0K) | 195.0K | 220.0K | 2.0M | 452.0K |
| Pre tax profit | (37.7M) | (608.0K) | (20.1M) | (17.7M) | (10.5M) |
| Income tax expense | 56.0K | 32.0K | 14.0K | 22.0K | 25.0K |
| Net Income | (37.7M) | (20.1M) | (17.8M) | (10.5M) | |
| EPS | (13.0) | (3.2) | (1.0) |